Skip to Content

Novavax says protein vaccine works for kids as young as 12

KTVZ

By The Associated Press

Novavax says its COVID-19 vaccine is proving safe and effective for kids as young as 12. The Maryland-based company makes a protein-based vaccine that’s been cleared for use in adults in parts of the world including Britain and Europe, and is under review in the U.S.  Novavax studied more than 2,000 U.S. kids ages 12 to 17 last summer. The company announced Thursday that the shots were 80% effective at preventing symptomatic COVID-19, and it plans to seek expanded use of the vaccine down to age 12.

Article Topic Follows: AP National News

Jump to comments ↓

Associated Press

BE PART OF THE CONVERSATION

KTVZ NewsChannel 21 is committed to providing a forum for civil and constructive conversation.

Please keep your comments respectful and relevant. You can review our Community Guidelines by clicking here

If you would like to share a story idea, please submit it here.

Skip to content